BGB-8035

DESCRIPTION

BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

DETAILS

Cas: 2283349-24-4
Purity: 98%
Smiles: C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4
Category: Compound
Molecular Weight: 453.53
Molecular Formula: C24H31N5O4

Lead Time: < 1 week